Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 96Carcinoma, Ovarian Epithelial 31Fallopian Tube Neoplasms 28Breast Neoplasms 25Carcinoma, Non-Small-Cell Lung 21Melanoma 20Uterine Cervical Neoplasms 16Pancreatic Neoplasms 14Neoplasm Metastasis 13Colorectal Neoplasms 13Stomach Neoplasms 11Triple Negative Breast Neoplasms 10Carcinoma, Hepatocellular 10Sarcoma 9Lung Neoplasms 9Head and Neck Neoplasms 9Recurrence 8Neoplasms 8Anus Neoplasms 8Multiple Myeloma 7Esophageal Neoplasms 7Sarcoma, Synovial 6Neuroblastoma 6Carcinoma, Renal Cell 6Vaginal Neoplasms 5Urinary Bladder Neoplasms 5Testicular Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Penile Neoplasms 5Lymphoma, Non-Hodgkin 5

Interventions

Mitomycin 7Hyperthermic Intraperitoneal Chemotherapy 5Oxaliplatin 4Doxorubicin 3Cisplatin 3Trastuzumab 2Leucovorin 2Irinotecan 2Fluorouracil 2tipifarnib 1sodium thiosulfate 1nilotinib 1motexafin lutetium 1irinotecan sucrosofate 1entinostat 1durvalumab 1dehydroftorafur 1Surveys and Questionnaires 1Referral and Consultation 1Quality of Life 1Psychiatric Rehabilitation 1Platinum 1Patient Reported Outcome Measures 1Paclitaxel 1Ondansetron 1Nutritional Status 1Molecular Diagnostic Techniques 1Mitozytrex 1Melphalan 1Laparoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Appendiceal Neoplasms × Cyclophosphamide × Gynecologic × Clear all
NCT02963831 2022-12-22

A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies

Ludwig Institute for Cancer Research

Phase 1/2 Completed
67 enrolled 16 charts
GastrointestinalGynecologic

Appendiceal Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡